Skip to main content

Norman Dovichi, Annelise Barron, Patrick Doyle, Richard Lussier, Duncan Whitney, James LeVoy Sorenson

Premium
Genome Corp. of Providence, RI, announced its scientific advisory board this week, which includes Norman Dovichi, Annelise Barron, and Patrick Doyle.
 
Dovichi is a professor of analytical chemistry at the University of Washington. While at the University of Alberta, he developed sheath flow detection for capillary electrophoresis, one of the key technologies used in ABI’s 3700 sequencer.
 
Barron is an associate professor of bioengineering at Stanford University. She has developed several sieving matrices for Sanger sequencing (see feature article in this issue) and has published work on read lengths of more than 1,300 bases. Until recently, she was a faculty member at Northwestern University.
 
Doyle is an associate professor of chemical engineering at the Massachusetts Institute of Technology, where he studies the dynamics of biopolymers and complex fluids, including theoretical and empirical studies of DNA migration during electrophoresis.
 

 
Richard Lussier has become chief operating officer and general manager at Progenika Biopharma. Most recently, he was at Solexa, which Illumina acquired a year ago, where he built a worldwide field organization to sell the Genome Analyzer. Previously, he held a number of technical, marketing, and management positions at Applied Biosystems and Celera Genomics, including general manager of Applera’s Japanese subsidiary.
 
Duncan Whitney has become Progenika Biopharma’s CSO. Previously, he was vice president of research and development at US Genomics. Before that, he was vice president of technology development at Exact Sciences, where he was responsible for commercializing novel DNA-based colon cancer diagnostic tests. He also held various positions at PerSeptive Biosystems, which later became part of Applied Biosystems. Whitney holds an undergraduate degree in chemistry from Colby College and a PhD from the Massachusetts Institute of Technology.
 

 
James LeVoy Sorenson, a medical device inventor and founder of companies, including Sorenson Genomics and Sorenson Forensics, died of cancer on Sunday at the age of 86.
 
Among the companies he founded were Deseret Pharmaceuticals, which was later acquired by Becton Dickinson, and Sorenson Research, which was acquired by Abbott Laboratories.
 
He also founded the non-profit Sorenson Molecular Genealogy Foundation, which has built a collection of correlated genetic and family history information in more than 170 countries.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.